The Oslo Balloon Angioplasty versus Conservative Treatment Study (OBACT)-The 2-years Results of a Single Centre, Prospective, Randomised Study in Patients with Intermittent Claudication

European Journal of Vascular and Endovascular Surgery

Volumn 33, Issue 1, 2007, Pages 3-12

  Nylaende M ^a   Abdelnoor, M ^b   Stranden, E ^a   Morken, B ^a   Sandbaek G ^a   Risum, O ^a   Jorgensen J J ^a   Lindahl, A K ^a   Arnesen, H ^b   Seljeflot, I ^b   Kroese, A J ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Exercise training; Optimal medical treatment (OMT); Percutaneous transluminal angioplasty (PTA); Quality of life (QoL); Treadmill walking distance

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART INFARCTION; HEMODYNAMICS; HUMAN; HYPERCHOLESTEROLEMIA; INTERMETHOD COMPARISON; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PAIN ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SAMPLE SIZE; SHORT FORM 36; STATISTICAL SIGNIFICANCE; STROKE; THERAPY EFFECT; TREADMILL; VISUAL ANALOG SCALE; WALKING;

EID: 33845250675     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.08.007     Document Type: Article

References (43)

1. Fowkes F.G.R., Housley E., Cawood E.H.H., MacIntyre C.C.A., Ruckley C.V., and Prescott R.J. Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20 (1991) 383-392
2. Kannel W.B., and McGee D.L. Update on some epidemiological features of intermittent claudication: the Framingham Study. J Am Geriatr Soc 33 (1985) 13-18
3. Dormandy J., Mahir M., Ascady G., Balsano F., De Leeuw P., Blombery P., et al. The fate of the claudicant - a prospective study of 1969 claudicants. J Cardiovasc Surg 30 (1989) 50-57
4. Golledge J. Lower limb arterial disease. Lancet 350 (1997) 1459-1465
5. Fowkes F.G., Housley E., Riemersma R.A., and Macintyre C.C. Smoking, lipids, glucose in-tolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 135 (1992) 331-340
6. Drexel H., Steurer J., Muntwyler J., and Meienberg S. Predictors of the presence and extent of peripheral arterial occlusive disease. Circulation 94 suppl. 1 (1996) II-199-II-205
7. Willegendael E.M., Tejink J.A.W., and Barteling M.L. Influence of smoking on the incidence and prevalence of peripheral arterial disease. J Vasc Surg 40 (2004) 1158-1165
8. Hughes J.R., Stead L.F., and Lancaster T. Adjunctive measures such as nicotine replacement therapy (NRT) and Bupropion have shown to make permanent smoking cessation more successful. Cochrane Database Syst Rev 2 (2003) CD0000031
9. Pell J.P., Campbell H., Cooper G., Drury J., and Duncan J.L. Impact of intermittent claudication on quality of life. Eur J Vasc Endovasc Surg 9 (1995) 469-472
10. Housley E. Treating claudication in five words. Br Med J 296 (1988) 1483-1484
11. Gardner A.W., and Poehlman E.T. Exercise rehabilitation programs for the treatment of claudication pain. JAMA 274 (1995) 975-980
12. Hart R.G., Halperin J.L., McBride R., and Benavente O. Aspirin for the primary prevention of stroke and other major vascular events. Arch Neurol 57 (2000) 326-332
13. Galliano A., Mahler F., Probst P., and Nachbur B. Percutaneous transluminal angioplasty of the arteries of the lower limbs: a five year follow-up. Circulation 70 (1984) 619-623
14. Doubilet P., and Abrams H.L. The cost of under utilisation. Percutaneous transluminal angioplasty for peripheral vascular disease. N Engl J Med 310 (1984) 95-102
15. Creasy T.S., McMillian P.J., and Fletcher E.W.L. Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective, randomised trial. Eur J Vasc Endovasc Surg 4 (1990) 135-140
16. Perkins J.M., Collin J., and Creasy T.S. Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. Eur J Vasc Endovasc Surg 11 (1996) 409-413
17. Whyman M.R., Fowkes F.G.R., and Kerracher E.M.G. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. Eur J Vasc Endovasc Surg 12 (1996) 167-172
18. Whyman M.R., Fowkes F.G.R., and Kerracher E.M.G. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomised, controlled trial. J Vasc Surg 26 (1997) 551-557
19. Fowkes F.G.R., and Gillespie I.N. Angioplasty (versus non surgical management) for intermittent claudication (Cochrane Review). The Cochrane Library Issue 4 (2000) Oxford; Update Software
20. Carter S. Clinical measurement of systolic pressures in limbs with arterial occlusive disease. JAMA 297 (1969) 1869-1874
21. Meaney J.F.M. Stepping-table gladolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology 211 (1999) 59-67
22. Myers C., and Wilks D. Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome. Qual Life Res 8 (1999) 9-16
23. Beattie D.K., Golledge J., Greenhalgh R.M., and Davies A.H. Quality of life assessment in vascular disease: towards a consensus. Eur J Vasc Endovasc Surg 13 (1997) 9-13
24. Mehta T., Venkata Subramaniam A.V., Chetter I., and McCollum P. Assessing the validity and responsiveness of disease-specific quality of life instruments in intermittent claudication. Eur J Vasc Endovasc Surg 31 (2006) 46-52
25. Mehta T., Venkata Subramaniam A.V., Chetter I., and McColllum P. Disease-specific quality of life assessment in intermittent claudication: review. Eur J Vasc Endovasc Surg 25 (2003) 202-208
26. Karnath B. Smoking cessation. Am J Med 112 (2002) 399-405
27. Hughes J.R., Stead L.F., and Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2 (2003) CD000031
28. Hiatt W.R., Hirsch A.T., Regensteiner J.G., and Brass E.P. Clinical functional status and clinical end points. Vascular clinical trialists. Circulation 92 (1995) 614-621
29. Ashworth N.L., Chad K.E., Harrison E.L., Reeder B.A., and Marshall S.C. Home vs. center based physical activity programs in older adults. Cochrane Database Syst Rev Issue 1 (2005) Art. No.: CD004017
30. Singh R.B., Dubnov G., Niaz M.A., Ghosh S., Singh R., Rastogi S.S., et al. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean diet heart study): a randomised single-blind trial. Lancet 360 (2002) 1455-1461
31. Goldhaber S.Z., Manson J.E., and Stampfer M.J. Low-dose aspirin and subsequent peripheral arterial surgery in the physicians Health Study. Lancet 340 (1992) 143-145
32. Collins R., Armitage J., Parish S., Sleight P., and Peto R. MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361 (2003) 2005-2016
33. Laws P.E., Spark J.I., Cowled P.A., and Fitridge R.A. The role of statins in vascular disease. Review. Eur J Vasc Endovasc Surg 27 (2004) 6-16
34. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342 (2000) 145-153
35. Guideline subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 17 (1999) 151-183
36. Capek P., McLean G.K., and Berkowitz H.D. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 83 2 suppl. (1991) 70
37. Klein W.M., Graaf Y., Seegers J., Spithoven J.H., Buskens E., Baal J.G., et al. (The Dutch Iliac Stent Trial Study Group). Dutch ilac stent trial: long-term results in patients randomized for primary or selective stent placement. Radiology 238 (2005) 734-744
38. Sapoval M.R., Long A.L., Raynaud A.C., Beyssen M.B., Fiessinger J.N., and Gaux J.C. Femoropopliteal stent placement. Long-term results. Radiology 184 (1992) 833-839
39. Khan S., Cleanthis M., Smout J., Flather M., and Stansby G. Life-style modification in peripheral arterial disease. A review. Eur J Vasc Endovasc Surg 29 (2005) 2-9
40. Nehler M.R., McDermott M.M., Treat-Jacobsen D., Chetter I., and Regensteiner J.D. Functional outcomes and quality of life in peripheral arterial disease: current status. Vasc Med 8 (2003) 115-126
41. Taft C., Karlsson J., and Geling J. Treatment efficacy of intermittent claudication by invasive therapy, supervised physical exercise training compared to no treatment in unselected randomised patients II: one year result of health-related quality of life. Eur J Vasc Endovasc Surg 22 (2001) 114-123
42. Wayne-Johnson K., Rae M., and Hogg-Johnson S.A. 5-year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg 206 (1987) 403-413
43. Taft C., Sullivan M., Lundholm K., Karlsson J., Gelin J., and Jivegard L. Predictors of treatment outcome in intermittent claudication. Eur J Vasc Endovasc Surg 27 (2004) 24-32